ChemicalBook >> CAS DataBase List >>P-2045
P-2045
- CAS No.
- 259746-53-7
- Chemical Name:
- P-2045
- Synonyms
- P-61A6;P-2045;MSEDBHSIUXXZNP-HSEDBPTHSA-N;Cyclo(N-methyl-L-homocysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-threonyl-L-phenylalanyl), (1→1')-thioether with 3-[(2-mercaptoacetyl)amino]-L-alanyl-4-amino-L-phenylalanyl-L-cysteinyl-L-threonyl-L-serine;(2S)-2-[[(2S,3R)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-amino-3-[[2-[2-[(2S,5S,8R,11S,14S,17S)-11-(4-aminobutyl)-17-benzyl-14-[(1R)-1-hydroxyethyl]-5-[(4-hydroxyphenyl)methyl]-8-(1H-indol-3-ylmethyl)-1-methyl-3,6,9,12,15,18-hexaoxo-1,4,7,10,13,16-hexazacyclooctadec-2-yl]ethylsulfanyl]acetyl]amino]propanoyl]amino]-3-(4-aminophenyl)propanoyl]amino]-3-sulfanylpropanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoic acid
- CBNumber:
- CB92582930
- Molecular Formula:
- C68H91N15O17S2
- Molecular Weight:
- 1454.68
- MDL Number:
- MFCD25977753
- MOL File:
- 259746-53-7.mol
Last updated:2022-12-21 16:56:50
Boiling point | 1809.0±65.0 °C(Predicted) |
---|---|
Density | 1.330±0.06 g/cm3(Predicted) |
pka | 2.96±0.10(Predicted) |
FDA UNII | QM5YSF1QO1 |
P-2045 Preparation Products And Raw materials
Raw materials
Preparation Products
Global( 8)Suppliers
Supplier | Tel | Country | ProdList | Advantage | |
---|---|---|---|---|---|
Alpha Biopharmaceuticals Co., Ltd | +86-411-39042497 +8613921981412 | sales@alphabiopharm.com | China | 888 | 58 |
Nextpeptide Inc | +86-0571-81612335 +8613336028439 | sales@nextpeptide.com | China | 19915 | 58 |
Hangzhou MolCore BioPharmatech Co.,Ltd. | +86-057181025280; +8617767106207 | sales@molcore.com | China | 49739 | 58 |
Alabiochem Tech.Co., Ltd. | 0512-58900862 400-0707518 | sales@alabiochem.com | China | 997 | 59 |
NCE Biomedical Co.,Ltd. | 4000-027-021 |24 +86-13986109188 | +86-15623472865 | +81-08033611988 | China | 1494 | 55 | |
SPIRO PHARMA | eric_feng1954@126.com | China | 9254 | 55 | |
Alabiotech Inc. | 001-619-354-5251 | sales@alabiotech-e.com | United States | 972 | 60 |
Alpha Biopharmaceuticals Co., Ltd | 0411-39042497 | sales@alphabiopharm.com | China | 1951 | 58 |
Supplier | Advantage |
---|---|
Alpha Biopharmaceuticals Co., Ltd | 58 |
Nextpeptide Inc | 58 |
Hangzhou MolCore BioPharmatech Co.,Ltd. | 58 |
Alabiochem Tech.Co., Ltd. | 59 |
NCE Biomedical Co.,Ltd. | 55 |
SPIRO PHARMA | 55 |
Alabiotech Inc. | 60 |
Alpha Biopharmaceuticals Co., Ltd | 58 |
P-2045
P-61A6
MSEDBHSIUXXZNP-HSEDBPTHSA-N
(2S)-2-[[(2S,3R)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-amino-3-[[2-[2-[(2S,5S,8R,11S,14S,17S)-11-(4-aminobutyl)-17-benzyl-14-[(1R)-1-hydroxyethyl]-5-[(4-hydroxyphenyl)methyl]-8-(1H-indol-3-ylmethyl)-1-methyl-3,6,9,12,15,18-hexaoxo-1,4,7,10,13,16-hexazacyclooctadec-2-yl]ethylsulfanyl]acetyl]amino]propanoyl]amino]-3-(4-aminophenyl)propanoyl]amino]-3-sulfanylpropanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoic acid
Cyclo(N-methyl-L-homocysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-threonyl-L-phenylalanyl), (1→1')-thioether with 3-[(2-mercaptoacetyl)amino]-L-alanyl-4-amino-L-phenylalanyl-L-cysteinyl-L-threonyl-L-serine
259746-53-7
C68H91N15O17S2